Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
SER Serina Therapeutics
- 4.620
- -0.170-3.55%
Close Jan 8 16:00 ET
- 4.620
- 0.0000.00%
Post 20:01 ET
43.39MMarket Cap-77.00P/E (TTM)
5.103High4.620Low11.95KVolume4.842Open4.790Pre Close58.62KTurnover0.34%Turnover RatioLossP/E (Static)9.39MShares22.82552wk High-3.15P/B16.10MFloat Cap3.81052wk Low--Dividend TTM3.48MShs Float209.262Historical High--Div YieldTTM10.07%Amplitude3.810Historical Low4.905Avg Price1Lot Size
About Serina Therapeutics Company
Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.
Company Profile
SymbolSER
Company NameSerina Therapeutics
Listing DateNov 29, 2018
Founded2024
CEOMr. Steven Ledger
MarketAMEX
Fiscal Year Ends12-31
Address601 Genome Way,Suite 2001
CityHuntsville
ProvinceAlabama
CountryUnited States of America
Zip Code35806
Phone1-256-327-9630
Company Executives
- Name
- Position
- Salary
- Steven Ledger
- Director and Chief Executive Officer
- 237.50K
- Dr. Randall W. Moreadith,M.D.,PhD
- Chief Development Officer
- 433.88K
- Gregory S. Curhan
- Chief Financial Officer
- --
- Dr. Srini Tenjarla, PhD
- Senior Vice President, CMC and Formulation
- --
- Dr. Simba Gill, PhD
- Chairman of the Board
- --
- Dr. Balkrishan Gill, PhD
- Executive Chairman of the Board
- --
- Dr. Richard Marshall, M.D.
- Independent Director
- --
- Steven M. Mintz
- Independent Director
- --
- Remy Gross
- Independent Director
- --
- J. Milton Harris, PhD
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.